QIAGEN N.V. (QGEN)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 45.69 |
| Open | 45.73 |
| Bid | 45.12 x 900 |
| Ask | 45.16 x 1000 |
| Day's range | 45.22 - 45.81 |
| 52-week range | 34.74 - 47.70 |
| Volume | |
| Avg. volume | 1,010,535 |
| Market cap | 10.087B |
| Beta (5Y monthly) | 0.42 |
| PE ratio (TTM) | 29.91 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.28 (2.94%) |
| Ex-dividend date | 30 Jan 2024 |
| 1y target est | N/A |
- Zacks
Here's Why Investors Should Retain QIAGEN (QGEN) Stock Now
QIAGEN's (QGEN) solid potential in the NGS platform buoys optimism for investors.
- Zacks
QIAGEN's (QGEN) QCI Interpret Gets European IVDR Certification
QIAGEN's (QGEN) Clinical Insight Interpret is the first NGS interpretation platform approved by IVDR for use in cancer and hereditary applications.
- Zacks
QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus
QIAGEN (QGEN) receives FDA clearance for the QIAstat-Dx respiratory syndromic testing panel for fast and accurate results.
© 2024 Yahoo. All rights reserved.